Serum Antibodies to Pneumolysin in Patients with Pneumonia
|
|
- Caren Cross
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLNCAL MCROBOLOGY, Jan. 1988, p /88/ $02.00/0 Copyright 1988, American Society for Microbiology Vol. 26, No. 1 Serum Antibodies to Pneumolysin in Patients with Pneumonia KRZYSZTOF KANCLERSK,12* SVEN BLOMQUST,3'4 MARTA GRANSTROM,' AND ROLAND MOLLBY' National Bacteriological Laboratory, S Stockholm,' Department of nfectious Diseases, Danderyd lospital, S Danderyd,3 and Vasteras Central Hospital, S Vasteras,4 Sweden, and National nstitute of Hygiene, Warsaw, Poland2 Received 15 June 1987/Accepted 18 September 1987 Serum antibodies to purified pneumolysin were determined by enzyme-linked immunosorbent assay (ELSA) in paired samples from 406 adult patients with community-acquired pneumonia and in samples from 184 healthy controls. A high sensitivity (83%) was obtained in patients with blood culture-confirmed pneumococcal pneumonia. n patients with a tentative pneumococcal diagnosis based on culture of samples from the sputum or the nasopharynx, 45% were positive by ELSA. The difference likely reflected the different relevance of cultural findings for the diagnosis of pneumococcal pneumonia. A significant rise in ELSA titer was found in 17% of the patients. When the diagnosis was also based on high titers, 25% were positive. Pneumococcal pneumonia diagnosed by the pneumolysin ELSA was significantly more common in the patients with a more severe disease and who required hospitalization (21 versus 5% for outpatients). Younger patients were more often positive for pneumococci as determined by high titers, while older patients showed titer rises. Mixed infections with other infectious agents were not uncommon. The finding of low titers in acute-phase samples from positive patients and in the youngest and oldest age groups of healthy controls were unexpected, indicating that further studies on the role of pneumolysin in pneumococcal disease are warranted. Pneumococcal infections are known to be common, but epidemiological studies have been hampered by limitations in the diagnostic methods (1, 2, 7). Diagnosis based on blood culture alone has a high specificity but low sensitivity and results in underestimates of incidence. Cultures from other sites may not yield representative samples because of the high rate of healthy carriers (5, 10, 11, 16, 21). Serological assays could therefore be of great help in the diagnosis of pneumococcal infections. Antibody response to type-specific capsular polysaccharides and to the C polysaccharide have been investigated, but the methods have disadvantages for routine use (4, 12, 17). n earlier studies (15, 18), we have shown that an enzymelinked immunosorbent assay (ELSA) with purified pneumococcal hemolysin (pneumolysin) as antigen is of use for the serological diagnosis of pneumococcal pneumonia. n the present study, this newly developed method was applied to the diagnosis of pneumococcal pneumonia in a group of mainly adult patients with community-acquired pneumonia. MATERALS AND METHODS Patients. Paired serum samples from 406 patients with community-acquired pneumonia were examined. The patients were seen as outpatients or admitted to the Department of nfectious Diseases, Danderyd Hospital, Danderyd, Sweden. The Department of nfectious Diseases serves a population of 720,000 people who live in the northern part of Stockholm County, Sweden. The study period was 15 months (December 1978 to February 1980). All patients over 6 years of age with respiratory symptoms were included in the study if they fulfilled the following criteria: (i) an infiltrate judged as pneumonic on chest X-ray; (ii) symptoms and signs of respiratory illness for less than 3 weeks; (iii) no hospitalization for the previous month; (iv) acute- and convalescent-phase sera available for serological testing. The acute-phase samples were drawn at the first visit or on * Corresponding author. admission (mean, 7 days, and range, 1 to 20 days, after the onset of disease), and the mean time for the convalescentphase sample was 3 weeks (range, 8 days to 12 weeks) after the first sample was obtained. The majority of patients were adults. Only 23 of 406 of the patients were children below 16 years of age. The mean age was 48 years (range, 9 to 98 years) for all patients (n = 406), 34 years (range, 9 to 79 years) for the outpatients (n = 99), and 53 years (range, 6 to 98 years) for the hospitalized patients (n = 307). The sex distribution was 49% males and 51% females. Healthy controls. Sera from 184 healthy individuals (age, 0 to 80 years) were examined as controls to find the upper limits of normal immunoglobulin G (gg) titers to pneumolysin in serum. Pneumolysin ELSA. Production and purification of pneumolysin, as well as the ELSA for the detection of gg antibodies to purified pneumolysin in serum, have been described previously in detail (9, 13, 15, 18). Briefly, highly purified pneumolysin, at a concentration of 2.5 ktg/ml, was used to coat cobalt-irradiated polystyrene microplates (M 129 B; Dynatech Laboratories, Plochingen, Federal Republic of Germany). A single point determination was made routinely at a serum dilution of 1:1,000, but higher or lower dilutions were also used when appropriate. Goat anti-human gg antisera conjugated to alkaline phosphatase (Sigma Chemical Co., St. Louis, Mo.) was used with p-nitrophenyl phosphate as the substrate. Volumes of 100,ul were used in each step, and all washings were done three times. The ELSA titer was defined as the A405 multiplied by the serum dilution factor. A significant rise in titers was defined as at least a twofold (100%) increase between the acute- and the convalescent-phase samples. The intra- and interassay variations were 10 to 15% and 15 to 20%, respectively. Serologic diagnosis of other infectious agents. Paired samples were tested by the complement fixation test for influenza virus types A and B, parainfluenza virus types 1 to 3, respiratory syncytial virus, adenovirus, Mycoplasma pneumoniae, and ornithosis and by the indirect immunofluores- 96
2 VOL. 26, 1988 DAGNOSS OF PNEUMOCOCCAL PNEUMONA BY ELSA 97 cent-antibody test for Legionella pneumophila. A significant rise in titers, i.e., at least a fourfold rise in titers by the complement fixation or the immunofluorescent-antibody test was found in 135 patients (see Table 2). Furthermore, 52 patients had high antibody titers to these antigens (see Table 3). Culture. A conventional culture of a sample from the nasopharynx was performed in all patients. From those who produced sputum, a culture to detect bacteria was performed as well. f the patient had not received antimicrobial therapy prior to the first visit as an outpatient or on admittance as an inpatient, one or three blood samples, respectively, were drawn for culture. Of 406 patients, 12 had pneumococcal bacteremia, while 56 had Streptococcus pneumoniae found in the nasopharynx, the sputum, or both (see Table 1). n addition, four patients were positive by immunoelectroosmophoresis for pneumococcal polysaccharide antigens in sputum. Haemophilus influenza was found in blood culture from 2 patients and in the sputum, the nasopharynx, or both from 50 patients. RESULTS Anti-pneumolysin titers in a healthy population. The occurrence of antibodies to pneumolysin was studied in 184 healthy individuals (age, 0 to 80 years) (Fig. 1). The lowest antibody levels were recorded in infants of less than 1 year of age and in adults older than 70 years. The highest titers were found in the group of children who were 8 to 15 years old. n sera from patients in these age groups, there were only a few (5 of 41) with titers lower than 200. The upper limit of normal values, set at the 95th percentile of the healthy controls, was 500 for children under 7 years of age, 700 for patients 8 to 50 years of age, and 500 for adults older than 50 years of age. The chosen 95% specificity for diagnosis by high titers allowed for 5% false-positive results by high titers in a patient material. Anti-pneumolysin titers in patients with pneumonia. Positive serology by determination of a significant rise in gg titers to pneumolysin was found in 70 of 406 (17%) patients with clinical pneumonia (Table 1). ncluding diagnosis by high titers, a total of 101 of 406 (25%) patients were positive. Patients with pneumococcal bacteremia were positive by pneumolysin ELSA in 10 of 12 (83%) cases (Table 1). Patients with S. pneumoniae in the nasopharynx, the spu s ' CD 100. * S W40 Age groups (years).rn s 8 WF B0 FG. 1. Age distribution of gg anti-pneumolysin titers in serum from healthy controls. Dots indicate actual values, and bars indicate mean values for each age group. 0 TABLE 1. Antibody response to pneumolysin in patients with clinical pneumonia Pneumococci n ELSA for pneumolysin with a titer: detected in: Blood 12 9 (75) 1 (8) 10 (83) Nasopharynx and (35) 6 (10) 27 (45) sputum Negative (12) 24 (7) 64 (19) Total (17) 31 (8) 101 (25) tum, or both were positive by serology in 27 of 60 (45%) cases. n addition, positive anti-pneumolysin titers were found in 64 of 334 (19%) patients that were negative on routine culture for pneumococci. Patients positive by both culture and a titer rise in ELSA received antibiotics prior to culture in 6 of 29 (21%) cases, while patients positive by a titer rise in ELSA but negative by culture or immunoelectroosmophoresis received antibiotics in 17 of 39 (44%) cases (P < 0.07, by the Fischer exact test). Antibody response to pneumolysin. (i) n relation to age. The distribution of the antibody response pattern used for diagnosis, i.e., rise of titers or high titers, as it correlates with age is shown in Fig. 2. n patients under 21 years of age, 24% were positive by high titers and 8% were positive by a rise in titers. n those above 30 years of age, a significant rise in titers became the dominant serologic finding. The rate of high titers in these patients in the older age groups was 5% or lower, with the exception of the patients of 41 to 50 years of age, in which 9% positive results by high titers was found. (ii) n relation to severity of disease. Of the 406 patients, 304 required hospitalization and 102 were treated as outpatients. Pneumococcal pneumonia based on a rise in titers (Table 1) was found in 65 of 304 (21%) hospitalized patients, and was significantly higher in this group (P < 0.001, by the chisquare test with the Yates correction) than in the 5 of 102 (5%) outpatients. Diagnosis of pneumococcal disease based on high titers showed an opposite distribution in the two groups, with 6 of 304 (2%) positive results in hospitalized tn c,3 30- w 20. c W N=1B / / f / N=31 l/ / ',- /p N= 66 _- l43 N- 52 Nz 59 N. 49 N= _ c i- l >00 Age group (years) FG. 2. Percentage of patients with rising and high antibody titers to pneumolysin in relation to age. Hatched bars indicate patients with high titers, and open bars indicate patients with rising titers. A significant rise in titers was at least a 100% increase between two samples, and high titers were those above the 95th percentile found in age-matched healthy controls.
3 98 KANCLERSK ET AL. patients and 14 of 102 (14%) positive results in outpatients (P < 0.01). Serologic evidence of mixed infection. A significant rise in titers to other infectious agents of the respiratory tract was obtained in 135 of 406 (33%) patients (Table 2). Rising titers to pneumolysin were seen in 18 patients, and high titers only were found in another 11 patients. A total of 29 (22%) patients were positive based on serology, and 8 of these 29 patients were also positive for S. pneumoniae based on culture. n an additional 52 patients, high titers to other infectious agents were suggestive of current or recent infection (Table 3). Among these patients, 10 had rising and 5 had high antibody titers to pneumolysin. Positive cultures of S. pneumoniae as well were found in 2 of 15 patients. Patients that were positive by blood culture and sputum and/or nasopharynx culture to H. influenza were positive by serology to pneumolysin in 6 of 52 (12%) cases (Table 4). Concomitant positive cultures of S. pneumoniae were obtained in two of six of these patients. Pneumolysin titers in early acute-phase samples. Acutephase samples drawn within 5 days after the onset of respiratory symptoms were available from 37 patients (median age, 63 years; range, 14 to 90 years), with a significant rise in titers. Titers above 200 were found in only nine (24%) of these patients. This rate was significantly lower than that (61 of 118 [52%]) found among all other patients who were negative by pneumococcal culture and ELSA (P < 0.01, by the chi-square test). The same significant difference was obtained in these patients in comparison with that obtained in 26 of 47 (5%) healthy age-matçhed controls. Also, very low titers (below 100) were found in as many as 11 of 37 (30%) patients with an ELSA titer rise, but in only 16 of 118 (14%) of the other patients and jn 4 of 47 (9%) of the control group (P < 0.05 for both comparisonss. DSCUSSON This is the first study in which ELSA has been used to detect antibodies to pneumolysin in a large prospective patient population with'community-acquired pneumonia. n this study, the sensitivity of the assay in cases confirmed by blood culture was 83%, which is similar to our previous results of 82% (15, 18). Patients with a presumptive diagnosis TABLE 2. Rise in titer of other infectious agents ELSA for pneumolysin nfectious agent n with a titer: nfluenza virus type A nfluenza virus type B il Parainfluenza virus types 1 to 3 Respiratory syncytial virus Adenovirus M. pneumoniae Ornithosis L. pneumophila Total (13) il (8) 29a (22) a Eight patients were also positive by culture for pneumococci, including one patient with S. pneumoniae in blood culture. TABLE 3. High titer of other infectious agents ELSA for pneumolysin nfectious agent n with a titer: nfluenza virus type A O O O O nfluenza virus type B Parainfluenza virus types 1 to 3 Respiratory syncytial virus Adenovirus O O O Q M. pneumoniae Ornithosis L. pneumophila Total (19) 5 (10) 15a (29) a Two patients were culture positive for pneumococci. of pneumococcal pneumonia based on culture of pneumococci from the nasopharynx, by culture or antigen detection in sputum, or both were positive by ELSA at a much lower rate (45%). This discrepancy in the rate of positive results by ELSA in cases verified by blood culture and in patients diagnosed by culture of S. pneumoniae from other sites has several explanations. One possibility is that bacteremic patients have a better antibody response than do nonbacteremic patients. This possibility cannot be excluded, but it seems less likely. Bacteremic patients often have a more severe clinical presentation and receive antimicrobial therapy rapidly after the onset of symptoms. Although early treatment with antimicrobial agents could even result in the absence of or a decreased antibody response, bacteremic patients were positive 83% of the time. A more likely explanations could reflect the often quoted difficulty of obtaining representative samples from patients with suspected pneumococcal pneumonia (2, 10, 14).`Blood culture remains the most (if not the only) reliable method; i.e., it has the highest specificity. Transtracheal aspirates are said to yield more representative samples than sputum (4). The relevance of the finding of pneumococci in cultures of nasopharyngeal swabs and sputum, i.e., its specificity for pneumococcal pneumonia, has not been established. The results from our two studies (15, 18) seem to indicate that culture from these sites has a low degree of specificity for the diagnosis of pneumococcal pneumonia. TABLE 4. Number of patients culture positive for H. influenza ELSA for pneumolysin H. influenzae with a titer: detected in: n Rising High Orishingh Blood 2 la 0 i Nasopharynx Sputum Nasopharynx and sputum Total 52 4 (8) 2 (4) 6b (12) a Pneumococci were also cultured from sputun. b Two patients were culture positive for pneumococci. J. CLN. MCROBOL.
4 VOL. 26, 1988 DAGNOSS OF PNEUMOCOCCAL PNEUMONA BY ELSA 99 The incidence rate of 17 to 25% pneumococcal disease by detection of pneumolysin by ELSA lies within the range of 11.5 to 76% in hospitalized adult patients given in earlier reports (1, 10, 19). Swedish studies have reported frequencies from 34 to 54% (3, 6). Several factors could influence the rate of pneumococcal pneumonia in samples from patients. Some studies were conducted in patients who acquired pneumonia in the hospital, while our study was entirely conducted in patients with community-acquired infections. The severity of the cases and the age group under study were also of importance. n the present study, one-fourth of the patients had a mild case of disease that did not require hospitalization, and the patients were younger (mean age, 48 years) than those studied previously. The epidemic situation for other agents that cause pneumonia could also influence the relative rate of pneumococcal disease. Our study was conducted during a year with an unusually high incidence of M. pneumoniae infections and with an unusually low rate of influenza virus type A activity. Mixed infections have been reported not to be rare (3, 7, 8, 14). Evidence of mixed infection was also found in the present study and in our earlier studies of patients with M. pneumoniae infection (15, 18). n the present study, the rate of patients positive for pneumolysin by ELSA for patients with M. pneumoniae infection was similar or slightly lower than that in the earlier studies (15, 18) (33 versus 22%, respectively). n the earlier studies (15, 18), the patients with viral infections were all negative by ELSA. The main difference seems to be the severity of the disease in the patient samples in the two studies. While all patients in the first studies (15, 18) with M. pneumoniae infection required hospitalization, only 53 of 120 (44%) required hospitalization in the present study. All patients with viral infections were not hospitalized in the earlier studies (15, 18), while 40 of 47 (85%) were hospitalized in the present study. The distribution of rising titers versus high titers in different age groups was an unexpected finding. Also, the finding that rising titers were significantly more common among the patients that required hospitalization was intriguing. The data could suggest that younger patients have more rapid antibody responses, and it is possible that they also start with higher antibody levels. The rapid antibody response could result in a milder clinical course of infection. Other observations also seem to raise the question of whether antibodies to pneumolysin could be of importance in the host defense against pneumococcal disease. The antibody pattern in the healthy controls showed very low titers in the youngest children and patients in the oldest age groups, who are most prone to develop pneumococcal disease. Also, the finding of very low titers in acute-phase samples of patients positive in the pneumolysin ELSA could indicate a relation to the immune status. Although these first observations in humans represent indirect indications, they imply that further studies on pneumolysin are warranted. To our knowledge, only one study has been done in experimental animals immunized with purified pneumolysin (20). The results indicated increased survival time after challenge with virulent pneumococci. n conclusion, diagnosis of pneumococcal disease in clinical samples could be greatly improved by the introduction of a serologic assay. The ELSA for pneumolysin, in which only one antibody class is used, could readily be used in routine diagnostic work. This assay showed a high sensitivity in cases of infection verified by blood culture. The lower sensitivity in pneumococcal disease tentatively diagnosed by culture from other sites is likely to be due to the lower specificity of these cultural findings. Some unexpected observations seem to indicate that antibodies to pneumolysin could have a more important role in host defenses than earlier suspected. ACKNOWLEDGMENTS Goran Sterner is gratefully acknowledged for stimulating discussions and support during this study. We also thank Eivor Norstrom and Maj Ringman for skillful technical assistance. This study was supported by grant 16X-2562 from the Swedish Medical Research Council and by grant from the Swedish Society for Medical Sciences. LTERATURE CTED 1. Austrian, R Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev. nfect. Dis. 3: Bassett-Connor, E The nonvalue of sputum culture in the diagnosis of pneumococcal pneumoniae. Am. Rev. Respir. Dis. 103: Berntsson, E., J. Blomberg, T. Lagergârd, and B. Trollfors Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur. J. Clin. Microbiol. 4: Coonrod, J. D., and D. P. Drennan Pneumococcal pneumonia. Capsular polysaccharide antigenemia and antibody responses. Ann. ntern. Med. 84: Davidson, M., B. Tempest, and D. L. Palmer Bacteriologic diagnosis of acute pneumonia: comparison of sputum, transtracheal aspirates, and lung aspirates. J. Am. Med. Assoc. 235: Fransén, H Clinical and laboratory studies on the role of viruses, bacteria, Mycoplasma pneumoniae and Bedsonia in acute respiratory illness. Scand. J. nfect. Dis. Suppl Fransén, H., and G. Tunevail Bacteria and serologic reactions against bacteria in patients hospitalized with acute respiratory illnesses. Scand. J. nfect. Dis. 1: Fransén, H., and S. Wolontis nfections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. Scand. J. nfect. Dis. 1: Granstrom, M.,. G. Julander, S.-A. Hedstrom, and R. Mollby Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infection. J. Clin. Microbiol. 17: Gray, B. M., G. M. Converse, and H. C. Dillon Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the 24 first months of life. J. nfect. Dis. 142: Hendley, J. O., M. A. Sande, P. M. Stewart, and J. M. Gwaltney Spread of Streptococcus pneumoniae in families.. Carriage rates and distribution of types. J. nfect. Dis. 132: Holmberg, H., A. Krook, and A.-M. Sjogren Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia. J. Clin. Microbiol. 22: Julander,. G., M. Granstrom, S.-A. Hedstrom, and R. Mollby The role of antibodies against alpha-toxin and teichoic acid in the diagnosis of staphylococcal infection. nfection 11: Kaijser, B., E. Berntsson, and B. Trollfors Serological diagnosis of pneumococcal pneumonia. J. nfect. 1(Suppl. 2): Kalin, M., K. Kanclerski, M. Granstrom, and R. Moliby Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J. Clin. Microbiol. 25: Kalin, M., and A. A. Lindberg Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination and expectorate, antigen determination and cultural procedures. Scand. J. nfect. Dis. 15: Kalin, M., and A. A. Lindberg Antibody response against the type specific capsular polysaccharide in pneumococcal
5 100 KANCLERSK ET AL. pneumonia measured by enzyme linked immunosorbent assay. Scand. J. nfect. Dis. 17: Kanclerski, K., M. Granstrom, M. Kalin, and R. Mollby Enzyme-linked immunosorbent assay (ELSA) for detection of antibodies to purified pneumococcal hemolysin (pneumolysin) in patients with pneumonia, p n Y. Kimura, S. Kotami, and Y. Shiokawa (ed.), Recent advances in streptococci and streptococcal diseases. Redbooks Ltd., Berkshire, England. 19. MacFarlane, J. T., R. G. Finch, M. J. Ward, and A. D. MacRae. J. CLN. MCROBOL Hospital study of adult community-acquired pneumonia. Lancet ii: Paton, J. C., R. A. Lock, and D. J. Hansman Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. nfect. mmun. 40: Rosén, C., P. Christensen, B. Hovelius, and K. Prellner A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres. Acta Otolaryngol. Stockholm 98:
Streptococcus pneumonia
Streptococcus pneumonia The pneumococci (S. pneumoniae) are gram-positive diplococci. Often lancet shaped or arranged in chains, possessing a capsule of polysaccharide that permits typing with specific
More informationAntibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults
International Journal of Infectious Diseases (2005) 9, 274 279 http://intl.elsevierhealth.com/journals/ijid Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract
More informationINFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)
INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) 1. Agent: Influenza viruses A, B, and C. Only influenza A and B are of public health concern since they are responsible for epidemics. 2. Identification:
More informationReceived 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006
CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2006, p. 361 364 Vol. 13, No. 3 1556-6811/06/$08.00 0 doi:10.1128/cvi.13.3.361 364.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation
More informationLipopolysaccharide, and Outer Membrane in Adults Infected with
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 984, p. 54-58 0095-37/84/54-05$0.00/0 Copyright 3 984, American Society for Microbiology Vol. 0, No. 6 Antibody Responses to Capsular Polysaccharide, Lipopolysaccharide,
More informationEvaluation of Serologic Assays for Diagnosis of Whooping Cough
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1988, p. 1818-1823 0095-1137/88/091818-06$02.00/0 Copyright 1988, American Society for Microbiology Vol. 26, No. 9 Evaluation of Serologic Assays for Diagnosis of
More informationSpecificity of Human Antibodies Reactive with Pneumococcal C Polysaccharide
INFECTION AND IMMUNITY, Apr. 2000, p. 2333 2337 Vol. 68, No. 4 0019-9567/00/$04.00 0 Specificity of Human Antibodies Reactive with Pneumococcal C Polysaccharide CARL E. FRASCH* AND NELYDIA F. CONCEPCION
More informationpoint-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital
point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical
More informationprospective study among adults requiring
Thorax 1995;50:543-547 Department of Infectious Diseases, University Hospital, Building 1, C5-P, PO Box 9600, 2300 RC Leiden, The Netherlands R Bohte R van Furth P J van den Broek Reprint requests to:
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationin the study. All patients had a history of acute to be caused by pulmonary embolism, bronchopulmonary
Thorax 1981 ;36:566-570 Causes of pneumonia presenting to a district general hospital RJ WHITE, AD BLAINEY, K JOY HARRISON, SKR CLARKE From the Departments of Medicine and Bacteriology, Frenchay Hospital,
More informationIdentification of Streptococcus pneumoniae in
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1975, p. 173-177 Copyright 01975 American Society for Microbiology Vol. 2, No. 3 Printed in U.S.A. Application of Counterimmunoelectrophoresis in the Identification
More informationKey words: Rapid diagnosis technique, Co-agglutination, Latex agglutination Counter immunoelectrophoresis, Cupsul antigens
Key words: Rapid diagnosis technique, Co-agglutination, Latex agglutination Counter immunoelectrophoresis, Cupsul antigens, Table 1 Sensitivity of CoA, and CIE Table 2 Results of detection of infectious
More informationChlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States
Product Code IF1250G Rev. J Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationJ07 Titer dynamics, complement fixation test and neutralization tests
avllm0421c (spring 2017) J07 Titer dynamics, complement fixation test and neutralization tests Outline titer, antibody titer dynamics complement, complement fixation reaction neutralization tests 2/35
More informationpneumonia 2015;6:48 56
pneumonia 2015 Aug 21;6:48 56 pneumonia Brief Report Anne B Chang a,b, Heidi Smith-Vaughan a,c, Theo P Sloots f, Patricia C Valery a, David Whiley f, Jemima Beissbarth a, Paul J Torzillo d,e a Menzies
More informationProcalcitonin in children admitted to hospital with community acquired pneumonia
332 Pediatrics, Hôpital, 82 Av Denfert-Rochereau, 7514 Paris, France F Moulin M Lorrot E Marc J-L Iniguez D Gendrel Microbiology, Hôpital J Raymond Statistics, Hôpital Cochin/Saint Vincent de Paul J Coste
More informationEnzyme-Linked Immunosorbent Assay for Mumps and
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1980, p. 319-323 0095-1137/80/04-0319/05$02.00/0 Vol. 11, No. 4 Enzyme-Linked Immunosorbent Assay for Mumps and Parainfluenza Type 1 Immunoglobulin G and Immunoglobulin
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationPneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?
Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges
More informationChlamydia MIF IgM. Performance Characteristics. Product Code IF1250M Rev. I. Not for Distribution in the United States
Product Code IF1250M Rev. I Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia
More informationCommunity acquired pneumonia a prospective UK study
408 Department of Paediatrics, Newcastle General Hospital, Westgate Road, Newcastle-upon-Tyne, UK P Drummond J Clark A Cant Public Health Laboratory Service, Newcastle-upon-Tyne, UK J Wheeler A Galloway
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More informationPrediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical
Thorax 1989;44:1031-1035 Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features Prepared on behalf of the British Thoracic Society Pneumonia Research
More informationImpact of vaccination on epidemiology in adults
Impact of vaccination on epidemiology in adults Jan Verhaegen 1. Data on prospective study on IPD in Belgium (2009-2011) 2. Evolution of capsular types of invasive isolates from adults after introduction
More informationFamily Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain
Family Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain The prevalence of potential pathogenic bacteria in nasopharyngeal samples from individuals with a respiratory tract
More informationRSV Surveillance in the U.S.
RSV Surveillance in the U.S. Susan I. Gerber, MD Respiratory Virus Program Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationLower respiratory tract infections
12 Community-Acquired : Bacteriological Profile and Microbiological Investigations Ravi Kumar 1, Canna Ghia 2, Shaumil Waghela 3, Harish Thanusubramanian 4, Gautam Rambhad 5 Introduction Lower respiratory
More informationEvaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella
JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationRespiratory Pathogen Panel TEM-PCR Test Code:
Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -
More informationHealth Board Logo. Post SARS Outbreak Surveillance. Report of possible or probable cases (Form version 1) February 11 th 2004
Post SARS Outbreak Surveillance Report of possible or probable cases (Form version 1) February 11 th 2004 This form is to be used for persons who fit the surveillance case definition of possible or probable
More informationDiagnosis of Pneumococcal Disease
Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for
More informationBenefits of the pneumococcal immunisation programme in children in the United Kingdom
Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received
More information3. Rapidly recognize influenza seasons in which the impact of influenza appears to be unusually severe among children.
07-ID-14 Committee: Title: Infectious Disease Influenza-Associated Pediatric Mortality Statement of the Problem: In 2004, CSTE adopted influenza-associated pediatric mortality reporting with a provision
More informationSpread of Streptococcus pneumoniae in Families. II. Relation of Transfer of S. pneumoniae to Incidence of Colds and Serum Antibody
THE JOURNAL OF INf'ECTlOUS DISEASES VOL. 132, NO.1 JULY 197:5 197:5 by the University of Chicago. All rights reserved. Spread of Streptococcus pneumoniae in Families. II. Relation of Transfer of S. pneumoniae
More informationUpper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University
Upper Respiratory Infections Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Disclosures None Objectives Know the common age- and season-specific causes of pharyngitis
More informationSerological evidence of Legionella species infection in acute exacerbation of COPD
Eur Respir J 2002; 19: 392 397 DOI: 10.1183/09031936.02.00256702 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Serological evidence of Legionella
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationRespiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract
Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory
More informationPNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality
Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and
More informationvaccination. Children enrolled in these clusters between 6 weeks and 6 months of age received a 2-dose primary vaccination schedule.
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationEvaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella
J Clin Pathol 1987;40:77-82 Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella pneumophila serogroup 1 T G HARRSON,* E DOURNON,t A G TAYLOR* From the *Division
More informationChlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome
J Microbiol Immunol Infect 2005;38:117-122 Tsai et al Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome Ming-Han Tsai 1, Yhu-Chering Huang 1, Chih-Jung
More informationPathogensinvolved in lower respiratorytract infectionsin generalpractice
Chapter III Pathogensinvolved in lower respiratorytract infectionsin generalpractice AW Graffelman, A Knuistingh Neven, S le Cessie, ACM Kroes, MP Springer, PJvan den Broek British Journal of General Practice
More informationADI_Res_Bull_2013_Pneumococcal_Vaccine_Tests
ADI_Res_Bull_2013_Pneumococcal_Vaccine_Tests Most non-vaccinated humans and some animals have a natural exposure to non-virulent strains Streptococcus pneumonia, and therefore contain high levels of antibodies
More informationIgG subclass deficiencies
IgG subclass deficiencies hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on IgG subclass deficiencies. It has been produced by the PID UK Medical Advisory
More informationFACTORS ASSOCIATED WITH DIAGNOSIS OF BACTERIAL PNEUMONIA IN CHILDREN OF NORTHERN THAILAND
FACTORS ASSOCIATED WITH DIAGNOSIS OF BACTERIAL PNEUMONIA IN CHILDREN OF NORTHERN THAILAND Charung Muangchana National Vaccine Committee Office, Department of Disease Control, Ministry of Public Health,
More informationRapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Eur Respir J 2003; 21: 209 214 DOI: 10.1183/09031936.03.00058802 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Rapid urinary antigen test
More informationM I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
More informationImpact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults
Respiratory Medicine (2006) 100, 884 891 Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Felipe Andreo a,, José Domínguez b, Juan Ruiz a, Silvia
More informationPNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID
PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Influenza Revised December 2014 Influenza 1.0 Provincial Reporting Confirmed cases of disease 2.0 Type
More informationDengue Infection at Children's Hospital of Bangkok
Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,
More informationPathogens of the Respiratory System
Pathogens of the Respiratory System Chapter 21, Pages 531-567 1. Respiratory System Introduction A. Anatomy (Pages 532-534) i. Upper Respiratory Track a. Nasal Hairs b. Paranasal Sinuses c. Nasal Chonchae
More informationThe role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis
The Turkish Journal of Pediatrics 2013; 55: 50-57 Original The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis Deniz Doğru 1, Sevgi Pekcan 1, Ebru Yalçın
More informationPneumococcal Disease and Pneumococcal Vaccines
Pneumococcal Disease and Epidemiology and Prevention of - Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
More informationDownloaded from:
Muller-Pebody, B; Crowcroft, NS; Zambon, MC; Edmunds, WJ (2006) Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiology and infection, 134 (6). pp.
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 1. The cumulative cases report since December 2010 and cases report during January to March 2015 During
More informationEarly February Surveillance of severe atypical pneumonia in Hospital Authority in Hong Kong. Initiate contacts in Guangdong
SARS: Aetiology JSM Peiris The University of Hong Kong & Queen Mary Hospital WHO SARS Laboratory Network Hospital Authority and Department of Health, HK Early February 2003 Surveillance of severe atypical
More informationRespiratory syncytial virus (RSV) and respiratory bacteria which comes first?
Respiratory syncytial virus (RSV) and respiratory bacteria which comes first? Prof. David Greenberg MD The Pediatric Infectious Disease Unit Soroka University Medical Center The Faculty of Health Sciences,
More informationC O M M U N I C A B L E D I S E A S E S S U R V E I L L A N C E B U L L E T I N V O L U M E 1 2, N O. 4
SURVEILLANCE FOR BORDETELLA PERTUSSIS, ATYPICAL BACTERIAL CAUSES OF PNEUMONIA, HAEMOPHILUS INFLUENZAE AND STREPTOCOCCUS PNEUMONIAE WITHIN THE SEVERE RESPIRATORY ILLNESS SURVEILLANCE PROGRAMME, 2013 Maimuna
More informationHaemophilus influenzae, Invasive Disease rev Jan 2018
Haemophilus influenzae, Invasive Disease rev Jan 2018 BASIC EPIDEMIOLOGY Infectious Agent Haemophilus influenzae (H. influenzae) is a small, Gram-negative bacillus, a bacterium capable of causing a range
More informationInfluenza Weekly Surveillance Bulletin
Influenza Weekly Surveillance Bulletin Northern Ireland, Week 4 (22 nd January 28 th January 2018) Summary In week 4, the surveillance data indicates a moderate seasonal flu activity, with indicators showing
More informationInfluenza-Associated Pediatric Mortality rev Jan 2018
rev Jan 2018 Infectious Agent Influenza A, B or C virus BASIC EPIDEMIOLOGY Transmission Transmission occurs via droplet spread. After a person infected with influenza coughs, sneezes, or talks, influenza
More informationSimultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)
From the Japanese Association of Medical Sciences The Japanese Association for Infectious Diseases Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR
More informationPneumococcal Pneumonia
INFECTION AND IMMUNITY, Dec. 1977, p. 617-623 Vol. 18, No. 3 Copyright ) 1977 American Society for Microbiology Printed in U.S.A. Complement-Fixing Antibody Response in Pneumococcal Pneumonia J. DONALD
More informationWhooping cough-a study of severity in hospital cases
Archives of Disease in Childhood, 1981, 56, 687-691 Whooping cough-a study of severity in hospital cases D A ROBINSON, B K MANDAL, A G IRONSIDE, AND E M DUNBAR Communicable Disease Surveillance Centre,
More informationEpidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell
LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationUnit II Problem 2 Microbiology Lab: Pneumonia
Unit II Problem 2 Microbiology Lab: Pneumonia - What are the steps needed to obtain a proper sputum specimen? You need the following: A wide-mouth labeled container. Gloves. Water. Mouth wash + tissues.
More informationAlberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD)
August 2011 Pneumococcal Disease, Invasive (IPD) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition August
More information'Influenza Research Unit, Public Health Laboratory, St Luke's Hospital,
Epidem. Inf. (1989), 103, 359-369 359 Printed in Great Britain Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding school E. A. GRILLI1, M. J. ANDERSON2 AND T. W. HOSKINS3 'Influenza
More informationRespiratory virus associated communityacquired pneumonia in Western Australian Children: case-control study
Respiratory virus associated communityacquired pneumonia in Western Australian Children: case-control study Mejbah Bhuiyan PhD Candidate, School of Paediatrics and Child Health The University of Western
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationCOUNTER IMMUNO ELECTROPHORESIS FOR THE DIAGNOSIS OF STREPT. PNEUMONIA AND H. INFLUENZAE PNEUMONIA
COUNTER IMMUNO ELECTROPHORESIS FOR THE DIAGNOSIS OF STREPT. PNEUMONIA AND H. INFLUENZAE PNEUMONIA Pages with reference to book, From 148 To 152 Farrukh Azmi, Jamuila Iqbal, Nasreen Nomani, Zahid Ishaque,
More informationEnzyme-Linked Immunosorbent Assay for Detection of Respiratory Syncytial Virus Infection: Application to Clinical Samples
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 329-333 95-1137/82/8329-5$2./ Vol. 16, No. 2 Enzyme-Linked Immunosorbent Assay for Detection of Respiratory Syncytial Virus Infection: Application to Clinical
More informationKey words: Chlamydia pneumoniae, acute upper resiratory infections, culture, micro-if method
Key words: Chlamydia pneumoniae, acute upper resiratory infections, culture, micro-if method Table 1 Prevalence of antibodies to C. pneumoniae in patients and control group There was no statistically significant
More informationPneumococcal vaccines. Safety & Efficacy. Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh
Pneumococcal vaccines Safety & Efficacy Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh Disclosure Slide X X I DO NOT have any significant or other financial relationships with industry
More informationReceived 13 June 1991/Accepted 4 November 1991
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1992, p. 318-322 0095-1137/92/020318-05$02.00/0 Copyright C 1992, American Society for Microbiology Vol. 30, No. 2 Quantitation of Pneumococcal C Polysaccharide in
More informationSerotypes of Streptococcus pneumoniae
INFECrION AND IMMUNITY, Dec. 1994, p. 5683-5688 0019-9567/94/$04.00+0 Copyright C 1994, American Society for Microbiology Vol. 62, No. 12 Immunization of Mice with Pneumolysin Toxoid Confers a Significant
More informationDetermination of Antibodies to Pneumococcal C Polysaccharide in Patients with Community-Acquired Pneumonia
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 88-814 Vol. 22, No. 5 95-1137/85/1188-7$2./ Copyright C) 1985, American Society for Microbiology Determination of Antibodies to Pneumococcal C Polysaccharide
More informationParainfluenza Virus Infection Among Adults Hospitalized for Lower Respiratory Tract Infection
134 arainfluenza Virus Infection Among Adults Hospitalized for Lower Respiratory Tract Infection Arthur Marx, Howard E. Gary, Jr., Barbara J. Marston, Dean D. Erdman, Robert F. Breiman, Thomas J. Török,
More informationThis investigation was performed to compare the efficacy and sensitivities of the DAS with DAS-A ELISAs and the
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1984, p. 259-265 95-1137/84/8259-7$2./ Copyright C) 1984, American Society for Microbiology Vol. 2, No. 2 Detection of Neisseria meningitidis Group A, Haemophilus
More informationSplenectomy Vaccine Protocol PIDPIC
Splenectomy Vaccine Protocol PIDPIC 6.24.14 Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid tissues where B cells are educated against encapsulated
More informationIs Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High-Risk Adults Possible?
MAJOR ARTICLE Is Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High-Risk Adults Possible? Edward E. Walsh, 1,3 Derick R. Peterson, 2 and Ann R. Falsey 1,3 Departments
More informationEmerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington
Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza
More informationRespiratory Syncytial Virus: Implications for Parenteral
INFECTION AND IMMUNITY, July 1982, p. 160-165 0019-9567/82/070160-06$02.00/0 Vol. 37, No. 1 Comparison of Enzyme-Linked Immunosorbent Assay and Neutralization Techniques for Measurement of Antibody to
More informationProspective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization
869 Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization Beatriz Rosón, Jordi Carratalà, Ricard Verdaguer, Jordi Dorca,
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending April
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationAstrovirus-associated gastroenteritis in children
Journal of Clinical Pathology, 1978, 31, 939-943 Astrovirus-associated gastroenteritis in children C. R. ASHLEY, E. 0. CAUL, AND W. K. PAVER1 From the Public Health Laboratory, Myrtle Road, Bristol BS2
More informationStudy objective: To investigate the clinical presentation of community-acquired Chlamydia
Clinical Presentation of Community- Acquired Chlamydia pneumoniae Pneumonia in Adults* Naoyuki Miyashita, MD, PhD; Hiroshi Fukano, MD; Niro Okimoto, MD, PhD, FCCP; Hiroki Hara, MD, PhD, FCCP; Koichiro
More informationEDUCATIONAL COMMENTARY PERTUSSIS
EDUCATIONAL COMMENTARY PERTUSSIS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationRespiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic. Webinar Agenda
Respiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic Wednesday, November 2, 2016 12:00 PM ET Webinar Agenda Agenda Welcome and Introductions William Schaffner, MD, NFID Medical Director
More informationkidney cells grown in 3 per cent inactivated horse serum, 5 per cent beef embryo significance of these observations is not clear at the present time
THE ISOLATION OF A NEW VIRUS ASSOCIATED WITH RESPIRATORY CLINICAL DISEASE IN HUMANS* BY WINSTON H. PRICE DEPARTMENTS OF EPIDEMIOLOGY AND BIOCHEMISTRY, JOHNS HOPKINS UNIVERSITY SCHOOL OF HYGIENE AND PUBLIC
More information